Indivior PLC - ESG Rating & Company Profile powered by AI
The assessment of Indivior PLC employs data from across the web and also from available filings by Indivior PLC. Scroll down to the end of the page for potential risks for Indivior PLC based on industry, location and size. The dashboard contains a Q&A table for Indivior PLC.
Indivior PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Indivior PLC | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Indivior PLC have an accelerator or VC vehicle to help deliver innovation?
Does Indivior PLC disclose current and historical energy intensity?
Does Indivior PLC report the average age of the workforce?
Does Indivior PLC reference operational or capital allocation in relation to climate change?
Does Indivior PLC disclose its ethnicity pay gap?
Does Indivior PLC disclose cybersecurity risks?
Does Indivior PLC offer flexible work?
Does Indivior PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Indivior PLC disclose the number of employees in R&D functions?
Does Indivior PLC conduct supply chain audits?
Does Indivior PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Indivior PLC conduct 360 degree staff reviews?
Does Indivior PLC disclose the individual responsible for D&I?
Does Indivior PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Indivior PLC disclose current and / or historical scope 2 emissions?
Does Indivior PLC disclose water use targets?
Does Indivior PLC have careers partnerships with academic institutions?
Did Indivior PLC have a product recall in the last two years?
Does Indivior PLC disclose incidents of discrimination?
Does Indivior PLC allow for Work Councils/Collective Agreements to be formed?
Has Indivior PLC issued a profit warning in the past 24 months?
Does Indivior PLC disclose parental leave metrics?
Does Indivior PLC disclose climate scenario or pathway analysis?
Does Indivior PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Indivior PLC disclose the pay ratio of women to men?
Does Indivior PLC support suppliers with sustainability related research and development?
Does Indivior PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Indivior PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Indivior PLC involved in embryonic stem cell research?
Does Indivior PLC disclose GHG and Air Emissions intensity?
Does Indivior PLC disclose its waste policy?
Does Indivior PLC report according to TCFD requirements?
Does Indivior PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Indivior PLC disclose energy use targets?
Does Indivior PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Indivior PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for Indivior PLC
These potential risks are based on the size, segment and geographies of the company.
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.